Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 2
2019 2
2020 1
2021 2
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

7 results

Results by year

Filters applied: . Clear all
Page 1
Response to Nahshon and Lavie.
de Kroon CD, de Jonge MM, Bosse T, van Asperen CJ. de Kroon CD, et al. Among authors: de jonge mm. J Natl Cancer Inst. 2022 Feb 7;114(2):322-323. doi: 10.1093/jnci/djab155. J Natl Cancer Inst. 2022. PMID: 34424271 Free PMC article. No abstract available.
Frequent Homologous Recombination Deficiency in High-grade Endometrial Carcinomas.
de Jonge MM, Auguste A, van Wijk LM, Schouten PC, Meijers M, Ter Haar NT, Smit VTHBM, Nout RA, Glaire MA, Church DN, Vrieling H, Job B, Boursin Y, de Kroon CD, Rouleau E, Leary A, Vreeswijk MPG, Bosse T. de Jonge MM, et al. Clin Cancer Res. 2019 Feb 1;25(3):1087-1097. doi: 10.1158/1078-0432.CCR-18-1443. Epub 2018 Nov 9. Clin Cancer Res. 2019. PMID: 30413523
Germline BRCA-Associated Endometrial Carcinoma Is a Distinct Clinicopathologic Entity.
de Jonge MM, Ritterhouse LL, de Kroon CD, Vreeswijk MPG, Segal JP, Puranik R, Hollema H, Rookus MA, van Asperen CJ, van Leeuwen FE, Smit VTHBM, Howitt BE, Bosse T; HEBON Group. de Jonge MM, et al. Clin Cancer Res. 2019 Dec 15;25(24):7517-7526. doi: 10.1158/1078-0432.CCR-19-0848. Epub 2019 Sep 6. Clin Cancer Res. 2019. PMID: 31492746
Endometrial Cancer Risk in Women With Germline BRCA1 or BRCA2 Mutations: Multicenter Cohort Study.
de Jonge MM, de Kroon CD, Jenner DJ, Oosting J, de Hullu JA, Mourits MJE, Gómez Garcia EB, Ausems MGEM, Margriet Collée J, van Engelen K, van de Beek I; Hebon Group; Smit VTHBM, Rookus MA, de Bock GH, van Leeuwen FE, Bosse T, Dekkers OM, van Asperen CJ. de Jonge MM, et al. J Natl Cancer Inst. 2021 Sep 4;113(9):1203-1211. doi: 10.1093/jnci/djab036. J Natl Cancer Inst. 2021. PMID: 33710348 Free PMC article.
Validation and Implementation of BRCA1/2 Variant Screening in Ovarian Tumor Tissue.
de Jonge MM, Ruano D, van Eijk R, van der Stoep N, Nielsen M, Wijnen JT, Ter Haar NT, Baalbergen A, Bos MEMM, Kagie MJ, Vreeswijk MPG, Gaarenstroom KN, Kroep JR, Smit VTHBM, Bosse T, van Wezel T, van Asperen CJ. de Jonge MM, et al. J Mol Diagn. 2018 Sep;20(5):600-611. doi: 10.1016/j.jmoldx.2018.05.005. Epub 2018 Jun 21. J Mol Diagn. 2018. PMID: 29936257 Free article.
The RECAP Test Rapidly and Reliably Identifies Homologous Recombination-Deficient Ovarian Carcinomas.
van Wijk LM, Vermeulen S, Meijers M, van Diest MF, Ter Haar NT, de Jonge MM, Solleveld-Westerink N, van Wezel T, van Gent DC, Kroep JR, Bosse T, Gaarenstroom KN, Vrieling H, Vreeswijk MPG. van Wijk LM, et al. Among authors: de jonge mm. Cancers (Basel). 2020 Sep 29;12(10):2805. doi: 10.3390/cancers12102805. Cancers (Basel). 2020. PMID: 33003546 Free PMC article.
The RAD51-FFPE Test; Calibration of a Functional Homologous Recombination Deficiency Test on Diagnostic Endometrial and Ovarian Tumor Blocks.
van Wijk LM, Kramer CJH, Vermeulen S, Ter Haar NT, de Jonge MM, Kroep JR, de Kroon CD, Gaarenstroom KN, Vrieling H, Bosse T, Vreeswijk MPG. van Wijk LM, et al. Among authors: de jonge mm. Cancers (Basel). 2021 Jun 15;13(12):2994. doi: 10.3390/cancers13122994. Cancers (Basel). 2021. PMID: 34203855 Free PMC article.